MedPath
HSA Approval

MERISLON TABLET 6 mg

SIN03047P

MERISLON TABLET 6 mg

MERISLON TABLET 6 mg

June 7, 1989

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.
Licence HolderDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N07CA01

betahistine

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

EISAI CO LTD (KAWASHIMA PLANT)

Active Ingredients

BETAHISTINE MESYLATE

6 mg

Betahistine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.